Results 111 to 120 of about 5,292 (153)

Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study. [PDF]

Med Sci Monit
Lu X, Wang X, Wang S, Huang J, Wei W, Kang F, Wang N.   +6 more
europepmc   +1 more source

Impact of learning curve on outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer patients at a specialized center. [PDF]

Rev Assoc Med Bras (1992)
Argın V, Özduman Ö, Sunar AO, Okuyan GÇ, Duman M, Polat E.   +5 more
europepmc   +1 more source

Impact of Accumulated Institutional Experience on Outcomes of Cytoreductive Surgery with Intraperitoneal Chemotherapy for Colorectal and Appendiceal Peritoneal Metastases: Early Versus Later Cohort Analysis. [PDF]

Cancers (Basel)
Suh JW, Kang H, Namgung H, Jo JW, Lee SC, Park DG.   +5 more
europepmc   +1 more source

Exploratory analysis of serial pan-immune-inflammation value and its early dynamics during neoadjuvant chemotherapy as a predictor of complete cytoreduction at interval debulking surgery in advanced ovarian cancer: a retrospective cohort study. [PDF]

World J Surg Oncol
Su H, Tian M, Wang Y, Li Y, Shan Y, Jin Y, Feng F, Wang T.   +7 more
europepmc   +1 more source

Locoregional Control from Complete Peritoneal Cytoreduction in Patients with Extraperitoneal Colorectal Cancer Metastases: An Entropy Balanced Analysis. [PDF]

Ann Surg Oncol
Tanweer MD, Paz IB, Lwin T, Melstrom L, Fong Y, Brar G, Castillo D, Kasi P, Fakih M, Raoof M.   +9 more
europepmc   +1 more source

Role of diagnostic laparoscopy in preoperative staging and resectability assessment for cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in peritoneal metastasis. [PDF]

Wideochir Inne Tech Maloinwazyjne
Kazanowski M, Lesiak P, Wierzbicki J, Kapturkiewicz B, Maciejewski P, Pawłowski M, Osuch J, Jastrzębski T, Bębenek M.   +8 more
europepmc   +1 more source

External Evaluation of a Predictive Model of Suboptimal Cytoreduction in Advanced Ovarian Cancer. [PDF]

Diagnostics (Basel)
Serra Rubert A, Ibañez Gual MV, Climent Martí MT, Bebia V, Gil-Moreno A, Díaz-Feijóo B, Veiga Canuto N, Muruzábal JC, Lopez-Gonzalez G, Tejerizo Á, Llueca A.   +10 more
europepmc   +1 more source

Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in suboptimally cytoreduced advanced ovarian cancer: a randomized phase II trial (PIPAC-OVA). [PDF]

BMC Cancer
Dzasokhov AS, Khomyakov VM, Turiev AV, Astashov VL, Kostin AA, Gunyakov SO, Andreeva MA.   +6 more
europepmc   +1 more source

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer: a retrospective cohort study using inverse probability of treatment weighting. [PDF]

World J Surg Oncol
Su H, Tian M, Wang Y, Li Y, Shan Y, Jin Y, Wang T, Feng F.   +7 more
europepmc   +1 more source

Case report: morbid obesity and lithotomy positioning: a high-risk triad with GCS leading to severe rhabdomyolysis with impending acute compartment syndrome following ovarian cancer cytoreduction. [PDF]

BMC Surg
Sun X, Tao W, Xu Z.
europepmc   +1 more source